A viable autosomal recessive mutation (named fch, or ferrochelatase deficiency) causing jaundice and anemia in mice arose in a mutagenesis experiment using ethylnitrosourea. Homozygotes (fch/fch) display a hemolytic anemia, photosensitivity, cholestasis, and severe hepatic dysfunction. Protoporphyrin is found at high concentration in erythrocytes, serum, and liver. Ferrochelatase activity in various tissues is 2.7-6.3% of normal. Heterozygotes (+/fch) are not anemic and have normal liver function; they are not sensitive to light exposure; ferrochelatase activity is 45-65% of normal. Southern blot analysis using a ferrochelatase cDNA probe reveals no gross deletion of the ferrochelatase gene. This is the first spontaneous form of erythropoietic protoporphyria in the house mouse. Despite the presence in the mouse of clinical and biochemical features unfrequent in the human, this mutation may represent a model for the human disease, especially in its severe form. (J. Clin.
Introduction
Ferrochelatase is the last enzyme on the heme biosynthesis pathway. It is present in mitochondria and catalyzes the insertion ofthe reduced form ofiron (Fe2") into protoporphyrin (1) .
In humans, erythropoietic protoporphyria is associated with a reduced activity of ferrochelatase (2) . The disease is characterized by cutaneous photosensitivity. A mild microcytic, hypochromic anemia is observed in a minority of cases. Fatalities from rapidly progressive liver disease have been reported in at least 20 patients (1) . Liver function tests are usually normal until shortly before liver failure becomes evident. Biochemically, erythropoietic protoporphyria (EPP)' results in accumulation of protoporphyrin in erythrocytes, plasma, and feces.
Although EPP is generally assumed to be an autosomal dominant hereditary condition, recent data suggest that the disease may be inherited, in some cases, in an autosomal recessive fashion (3, 4) .
Receivedfor publication 1I January 1991 and in revisedform 24 May 1991. 1 . Abbreviations used in thispaper: ENU, ethylnitrosourea; EPP, erythropoietic protoporphyria; GF, griseofulvine. Ferrochelatase deficiency has been described in cattle (5) . Affected cows develop skin lesions after exposure to sunlight but, unlike human, they do not develop anemia or hepatobiliary disease (6) . Bovine protoporphyria is transmitted as an autosomal recessive trait.
We describe here ferrochelatase deficiency in the house mouse, observed after a chemical mutagenesis experiment with ethylnitrosourea (ENU) . Affected animals exhibit a mild anemia with a high reticulocyte count, photosensitivity, and dramatic hepatobiliary dysfunction with jaundice from the early days of life onwards. This condition is transmitted in an autosomal recessive fashion and represents the first genetically determined mouse model for human erythropoietic protoporphyria. The mutation has been named "ferrochelatase deficiency" (fch).
Methods
Animals. The first mutant arose during in-breeding after a mutagenesis experiment in which males from an inbred strain carrying eight recessive mutations were injected with 250 mg/kg ethylnitrosourea (Sigma Chemical Co., St. Louis, MO). After successive matings with 129/Sv and BALB/c inbred strains, inbreeding was carried out. After a few generations of brother-sister mating, three mice in a litter of 10 displayed icteric sera. This characteristic appeared to be transmitted as a simple mendelian recessive trait. Homozygous males (fch/fch) from this pedigree were crossed with normal BALB/c females. The obligate heterozygous male offspring (+/fch) were crossed in turn with normal BALB/c females to produce heterozygous (+/fch) and normal (+/+) males. Heterozygotes (+/fch) were identified by crossing with an homozygous female (fch/fch). The same process was repeated with the goal of introducing the fch mutation into the BALB/c background. Observations were made on these animals, during the process of backcrossing, using BALB/c as controls (+/+). Linkage experiments were performed using several mutations which affect the coat color or the skeleton, and located on mouse chromosomes 1-1 1, 13, 15, and 17. In particular, we used leaden (In) for chromosome 1, brown (b) for chromosome 4, albino (c) for chromosome 7, Sombre (Es)) for chromosome 8, and waved-2 (wa-2) for chromosome 1 1. Southern blot analysis. High-molecular weight DNA was prepared from six +/+, +/fch, and fch/fch adult mice, according to standard protocols. 10 ,g of each DNA were digested with the following restriction enzymes: Bam HI, Eco RI, Hind III, Sac I, Taq I, and Xba I, under recommended conditions. Digested DNAs were electrophoresed in 0.8% agarose gels and transfered on Hybond N+ filters (Amersham), as originally described by Southern (7) .
Ferrochelatase cDNA was obtained from Taketani (8 Red cell osmotic resistance was tested on three mutants and three normal mice, aged 3 mo or more, using a standard protocol (11) . The density distribution curve of erythrocytes was obtained according to the method described by Danon and Marikovsky (12) .
Dried blood films were examined with Wright-Giemsa stain and by Perl's method for iron. Biochemical methods. The usual biochemical parameters, conjugated and unconjugated bilirubin, transaminases, and alkaline phosphatases were determined by using a model SRA 2000 system (Technicon Instruments Corp., Tarrytown, NY) or a Paramax (Baxter Healthcare Corp., Deerfield, IL).
Hemoglobins were analyzed by cellulose acetate electrophoresis (13) . Globin chains synthesis was analyzed after incorporation of 3H-leucine into blood reticulocytes by PAGE in urea and Triton X 100 (14) followed by autoradiography.
Ferrochelatase activity was measured by a radiochemical method using "Fe and mesoporphyrin as substrate, as described by Deybach et al. (15) . Protoporphyrin was determined by the method of Schwartz et al. (16) or separated and quantitated as methyl esters using HPLC with spectrofluorometric detection (17) .
Histology. Liver, bone marrow, and spleen were examined after Bouin's fixation, Paraplast embedding, and hematein-eosin staining.
Results Clinicalfeatures
Allfch/fch mutant mice are recognizable by the intense yellow color oftheir sera and, often, by gross bilirubinuria. Jaundice is usually apparent, especially in unpigmented albino mice. It is most severe in pups and young adult mice and often decreases slightly after a few months of age.
Photosensitivity was observed in fch/fch homozygotes under standard husbandry conditions (fluorescent light). Inflammatory lesions appear on ears and back, which often become ulcerous. No photosensitivity was observed in heterozygotes.
Youngfch/fch homozygotes do not show any difference in size or body weight, compared to normal sibs, nor are they retarded in growth. However, they have enlarged livers and spleens, from the early days of life onwards (Table I) . After a few months of age, they exhibit an enlarged abdomen (due to hepatomegaly and splenomegaly), decreased fat tissue and hypoactivity. Fertility appears to be reduced in both sexes, probably as a result of the general bad condition of affected animals.
Heterozygotes sometimes have a slightly icteric sera at 3 wk of age, but this disappears by adult age.
Genetical analysis Segregation analysis. Animals were recorded as mutants when they exhibited icteric sera at both 3 wk of age and at adult age (6-12 wk of age). When mutant mice were intercrossed, all the progeny (45 out of 45) were affected. Matings between affected and normal BALB/c mice produced no mutant progeny (out of > 50 animals). These progeny were considered as obligate heterozygotes. Intercrosses between these putative heterozygotes yielded 33 affected animals out of 173 progeny (19%, not significantly different from the expected value 25%). Crosses between putative heterozygotes and affected homozygotes produced 53% affected offspring (50 out of 95). These data are compatible with the inheritance pattern ofa single autosomal recessive gene.
Test of allelism. This new mutation was compared to already described mutations causingjaundice or anemia in mice. The mutation was found not to be an allele ofthe spherocytosis (sph) and Hertwig's anemia (an) loci.
Linkage experiments. No genetic linkage was found between the fch mutation and any of the markers which have been tested. Subsequently, the fch mutation was found to be linked neither to the albino locus (c) which is in the vicinity of the f3-globin gene on mouse chromosome 7, nor to the waved-2 locus (wa-2) which is close to the a-globin gene on mouse chromosome 1 1.
Southern blot analysis. For each of the six enzymes tested, all +/+, +/fch andfch/fch animals exhibited the same hybridization pattern with the ferrochelatase cDNA probe (not shown).
Hematological studies
The results of hematological studies are shown in Fig. 1 and Table II . Homozygous fch/fch animals were not anemic at 1 mo of age but normocytic anemia developed with age. Polychromasia, anisocytosis, target cells, and leptocytes were observed on blood films (Fig. 2) . The red cell volume range distribution width was found to be increased in 3-6 mo oldfch/fch mice (34.9, as compared to 21.6 in +/+ controls). Reticulocytosis was markedly increased (14% in homozygotes instead of 3% in normal controls or heterozygotes). Perl's staining revealed no siderocytes or excess sideroblasts in bone-marrow smears which contained an increased proportion of erythroblasts. The osmotic fragility oferythrocytes from homozygousfch/ fch mice was slightly decreased. 50% osmotic lysis offch/fch red cells occurred at a saline concentration of0.46% compared to a figure of 0.53% for control red cells. The slope was also less (Fig. 4) .
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Discussion
The new fch mutation, observed after chemical mutagenesis, produces in fch/fch mice a dramatic increase in the level of 7 protoporphyrin in erythrocytes, plasma, liver, and stool, hemolytic anemia and hepatic abnormalities which mimic the biochemical features found in the severe forms of human EPP rch/fch mice (five (18) . These abnormalities are due to a pronounced specific deficiency of ferrochelatase activity, with < 7% residual activity found in all tissues tested (Table IV) . Because of its very high erythropoietic activity, the spleen was used instead of bone sed heterogenemarrow to estimate the level of enzymatic activity. Heterozygous (+/fch) mice display normal biochemical and hematocreased density logical values (Tables II and III) show disequilibrium between a and P globin chain synthesis.
These results clearly show thatfch is not linked to globin genes. Erythrocytes are heterogenous in hemoglobin content (some are very hypochromic) and in size (as shown by the increased range distribution width). They have a decreased density, which is a very sensitive parameter for detecting cells with a low hemoglobin concentration, and a higher resistance to hypoosmolarity. These features may be related in part to the reticulocytosis. They also suggest a slightly decreased hemoglobin synthesis which can be attributed to the profound deficiency in ferrochelatase ofthe highly erythropoietic spleen and not to a thalassemic determinant. Portal hypertension, hypersplenism, and cholestatic jaundice may have enhanced the hematological abnormalities. There is no indication of an iron metabolism defect in erythroblasts, as evidenced by Perl's staining and electron microscopy of bone marrow and spleen.
We could not test allelism for all other recessive mutations causing anemia in mice, mainly because we could not get mutant mice from holders. However, we were able to discard most of these loci, partly because of a very different phenotype (19, 20) , partly according to results from linkage experiments.
Scheufler (21) has described an anemia in the mouse (hbd, hemoglobin deficit) associated with a high level of free red cell protoporphyrin. This anemia is mild, hypochromic and microcytic. It is not associated with hyperbilirubinemia, or with liver abnormalities (22) .
The only spontaneous animal model of EPP has been described in cows (5) . It is associated with a photosensitizing disease, transmitted as a recessive trait (6) . Ferrochelatase activity A biochemical protoporphyria phenotype can be easily experimentally induced in mice using griseofulvine (GF) as an inhibitor of ferrochelatase (25) . It has been used as an experimental model for human EPP but the site of excess protoporphyrin synthesis in GF-induced mice is thought to be the liver, despite erythrocyte protoporphyrin concentration can become comparable to that observed in human EPP (26).
Human EPP is an hereditary disorder of heme synthesis characterized clinically by early skin photosensitivity, mainly in the form of burning and oedema shortly after exposure to sunlight. It is characterized biochemically by an increased level of protoporphyrin IX in red cells, plasma and feces, as the consequence of deficient ferrochelatase activity. The disease usually takes a benign course. Photosensitivity is thought to be produced by photochemical activation of the excess protoporphyrin. A minority ofpatients show a mild hypochromic microcytic anemia.
The inheritance ofhuman EPP has been generally assumed to be as an autosomal dominant trait, but with partial penetrance (1, 27) . However, latent cases seem to be very common. A study on 91 Dutch families (28) concluded that the disease followed a recessive mode of transmission but this study was based only on phenotypic features (fluorocytes in blood) and not on ferrochelatase activity measurements. Nevertheless, the profound enzymatic defect repeatedly found in patients (10-30% of normal) compared to the defect in asymptomatic carriers (40-50% of normal) (3) and the recent reports of a recessive mode of transmission of the ferrochelatase defect (3, 4) associated with clinical features similar to those observed in usual cases suggest that EPP is not transmitted as a simple dominant trait but may require more than a single gene defect for disease expression.
The hepatic defects represent a major and constant feature in thefch/fch mouse. Hepatomegaly is observed from the early days oflife onwards and increases with age. It is associated with cholestasis, as shown by the high levels of conjugated bilirubin and alkaline phosphatase activity, and dilation of intrahepatic biliary ducts containing crystals. Unconjugated bilirubin is less affected, indicating that the hepatic conjugation system is very active but saturated, in relation to the increased hemolysis. Cirrhosis and hepatocyte dysfunction are documented by elevated transaminases and light and electron microscopy showing degenerated hepatocyte and fibrosis. Crystals, most probably of protoporphyrin, which is produced in excess by the er- ythron, are present in hepatocytes and Kupffer cells. These crystals are likely to be responsible for cholestasis, which in turn explains the increase of conjugated bilirubin, an unusual feature in hemolytic anemia.
In the human EPP, a fairly large number of patients suffer from cholelithiasis with gallstones made of protoporphyrin complexes. The severity ofthe disease is related in a minority of cases to fibrosis and even cirrhosis of the liver, but acute liver failure is not frequent (1). Light and electron microscopic examination of liver biopsies from human EPP patients have revealed a wide variability in findings, ranging from normality to periportal fibrosis and severe cirrhosis. Accumulation ofprotoporphyrin has been detected as brown pigments in hepatocytes, Kupffer cells and biliary canaliculae. A recent study (29) concluded that ultrastructural changes in the hepatic parenchymal cells are present in early stages ofthe disease. Moreover, biliary canalicular abnormalities responsible for cholestasis were observed, similar to that described in rat livers perfused with protoporphyrin (30) .
Human EPP thus remains controversial with regard to its pathophysiological aspects, mode of inheritance, skin phototoxicity, liver injury, and treatment. The source of excess protoporphyrin seems to be the erythron as suggested by the recent liver transplantation reports in EPP patients (31) . However, the mechanism of liver injury, appropriate markers to detect patients at risk of liver failure and then appropriate therapy are some important aspects which an animal model, like the fch/ fch mouse, could help clarify.
Conclusion
The fch mutation is characterized by a ferrochelatase deficiency. In the homozygous state, this mutation is responsible for more severe anemia and hepatic dysfunction than the human disease. In contrast, heterozygotes remain asymptomatic at 1 yr ofage, but their long-term clinical evolution will have to be assessed. The mutation will be localized on the mouse chromosomes. Molecular studies will be attempted to check whether the ferrochelatase gene is affected, or not.
Despite differences in inheritance and penetrance of the severe hepatic phenotype, this mutation represents a useful model to study the pathophysiological features of the human disease. Bone marrow transplantation experiments will provide indications on the major source of excess protoporphyrin production. Putative risk factors could be identified to predict severe liver injury. Treatments could also be attempted to prevent or to stop the progression ofthe disease (chenodesoxycholic acid, hematin transfusion).
